Simvastatin and the Rho-Kinase Inhibitor Y-27632 Prevent Myofibroblast Transformation in Peyronie's Disease-Derived Fibroblasts via Inhibition of YAP/TAZ Nuclear Translocation

BJU International - United Kingdom
doi 10.1111/bju.14638
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Wiley

Related search

Simvastatin and the Rho-Kinase Inhibitor Y-27632 Prevent Myofibroblast Transformation in Peyronie’s Disease-Derived Fibroblasts via Inhibition of YAP/TAZ Nuclear Translocation

European Urology, Supplements
Urology
2019English

Inhibition of Agonist-Induced Positive Inotropy by a Selective Rho-Associated Kinase Inhibitor, Y-27632

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2003English

The Rho Kinase Inhibitor Y-27632 Improves Motor Performance in Male SOD1G93A Mice

Frontiers in Neuroscience
Neuroscience
2014English

Prolonging Culture of Primary Human Keratinocytes Isolated From Suction Blisters With the Rho Kinase Inhibitor Y-27632

PLoS ONE
Multidisciplinary
2018English

Contact Inhibition Controls Cell Survival and Proliferation via YAP/TAZ-autophagy Axis

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2016English

Leukotriene C4enhances the Contraction of Porcine Tracheal Smooth Muscle Through the Activation of Y-27632, a Rho Kinase Inhibitor, Sensitive Pathway

British Journal of Pharmacology
Pharmacology
2001English

Rho Kinase Inhibitor HA-1077 Prevents Rho-Mediated Myosin Phosphatase Inhibition in Smooth Muscle Cells

American Journal of Physiology - Cell Physiology
PhysiologyCell Biology
2000English

Rho-Signaling-Directed YAP/TAZ Activity Underlies the Long-Term Survival and Expansion of Human Embryonic Stem Cells

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy